Clinical trial
Combination Chemotherapy Following Surgery in Treating Women With Early Stage…
NCT00003012 · Scottish Cancer Therapy Network, Other · Completed
Key facts
| NCT number | NCT00003012 |
|---|---|
| Title | Combination Chemotherapy Following Surgery in Treating Women With Early Stage Breast Cancer |
| Official title | A Prospective Randomized Comparison of CMF Versus Sequential Epirubicin Followed by SMF as Adjuvant Chemotherapy for Women With Early Breast Cancer |
| Lead sponsor | Scottish Cancer Therapy Network, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | CMF regimen, cyclophosphamide, epirubicin hydrochloride, fluorouracil, methotrexate |
| Enrollment | 1,000 |
| Start date | Oct 1, 1996 |
| First posted | Apr 6, 2004 |
| Last update posted | Nov 6, 2013 |
| Countries | United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: